Phone: 800-926-4797 or 941-312-0400
Your membership provides this website - Join Today!

 

HOME

BE INFORMED
  
> About PWS
  
> Get Publications
 
 > About PWSA (USA)
        
Board of Directors
        
Adults with PWS Advisory
       
 Office Staff

MEDICAL
   > Health Concerns
 
 > Medical Alert
  
> Psychiatric
  
> Diet Resources
  
> Growth Hormone

RESEARCH
   >
Research Grants
   >
Funded Research

   > Participants Wanted
   > Research Topics
   > Scientific Advisory Board
   > Clinical Advisory Board

GET INVOLVED
 
  > Spread Awareness
  
> Become member
   >
Registry

SUPPORT
  
 > Newly Diagnosis
   >
Non-Medical

 
 > For Families
  
> For Providers
           
Advisory Board
   >
For Educators

   > State Chapters
   > Links and Resources

MEDIA

GIVE

CONTACT US

 

 

Prader-Willi Syndrome and Early-onset Morbid Obesity Natural History Clinical Study

The purposes of this study are to a) evaluate effects of growth hormone treatment in people with Prader-Willi Syndrome (PWS) when started at different ages, b) compare people with PWS to people with early-onset morbid obesity (EMO), and c) collect information to use as a foundation for future research studies. Information gained from this study may help tailor long term management for individuals with PWS and EMO. This research study is being conducted under the auspices of the Rare Disease Clinical Research Network (RDCRN) at currently 4 institutions across the USA. It is funded by the NIH.

To learn more about the study and eligibility, go to http://rarediseasesnetwork.epi.usf.edu/  

More information about this study [click here]

Please note that some individuals may not qualify for the study and some sites may have already recruited enough subjects at the present time.

 

edited: 02/09/2012

Return to Home page

PWSA(USA) Disclaimer 

Membership
Payments

PWSA (USA)
Privacy Policy

PWSA (USA) Link Policy

Email PWSA(USA)

 Email Webmaster